7 Software Startups Showcase in the Korea National Pavilion at Slush
19.10.2020 10:00:00 EEST | Business Wire | Press release
Startups with new technologies and innovative platforms that are from Korea will participate in 2020 Node by Slush. Node by Slush is a curated community of Slush that connects startups with investors, partners, and mentors. Due to the COVID-19, 2020 Node by Slush (https://www.slush.org/node-by-slush) is held virtually in Helsinki.
The Korea national pavilion supports the promising 7 Korean startups to feature their advanced technologies and platforms in Slush, which is organized to empower entrepreneurs all around the world.
Ministry of Science and ICT (MSIT) and National IT Industry Promotion Agency (NIPA) of Korea support startups to scale up and find new marketplaces. MSIT and NIPA currently operate an acceleration program for the nurturing of software startups by encouraging them to expand the global market.
7 startups will showcase in a virtual booth installed in the Korea national pavilion.
- MOIN, a cross-border blockchain-based remittance company, provides transactions to 30 countries from Korea. This company works with other global money transfer companies to send money to Korea.
- Lablup is a startup that provides machine learning platforms and solutions to make AI accessible.
- Yalla factory is a music tech startup, generating chords for music instruments backed with differentiated music analyzing and transforming technology.
- Apposter provides a watch face DIY platform (named Mr. time maker) to create various dial designs for smartwatch by online. Users can make, share and do business with their own dial design.
- MOJITOK (Platfarm) is to make an emotionally connected world by designing a universal visual language and going beyond what static text and emojis can capture. Mojitok provides an extensive library of animated stickers so that there is always something for everyone.
- MARVRUS is an EdTech startup that provides emotion analysis solutions and immersive content to companies in the education, entertainment, and retail business.
- Il is a fashion tech company, developed 210.jewelry, a customized jewelry distribution platform that connects designers and consumers.
KOSA (Korea Software Industry Association) and Yozma Group, a Korean startup accelerator, have helped startups successfully enter the global market.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005263/en/
Contact information
Yozma Group Korea
Eunha Jeong
+82-2-6949-5340
eunha.jeong@yozma.asia
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery26.2.2026 13:49:00 EET | Press release
The Wyss Center for Bio and Neuroengineering Geneva announced today the successful closing of the Seed financing round of Clee Medical SA, a Swiss neurotechnology spin-off developing ultra-high-resolution real-time intraoperative imaging for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, and Venture Kick joining existing investors Wyss Center Geneva. Clee Medical spun-out from Wyss Geneva’s Minimally Invasive Intracranial Access (MICA) research project in December 2024. Its flagship platform, Neuro Access, combines OCT imaging with advanced navigation to help neurosurgeons visualize brain anatomy and critical structures in real time during stereotactic procedures. “Clee Medical not only holds the promise of improving patient outcomes but also highlights Wyss Geneva’s dedication to bridging the gap between scientific discovery and real-world impact.” Dr. Erwin Böttinger, CEO, Wyss Geneva “Neurosurg
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants26.2.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were issued on January 13, 2025, for proceeds of approximately $200 million. Upon exercise of these outstanding warrants, Compass Pathways is issuing 15,160,619 American Depositary Shares (“ADSs”) and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 19,898,829 ADSs. Compass Pathways currently intends to use the proceeds from these warrant exercises, together with its existing cash and cash equivalents, to fund ongoing COMP005 and COMP006 Phase 3 trials, its Phase 2b/3 trial of COMP360 in PTSD, acceleration of its commercial readiness activities, and for working capital and general corporate purposes. The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on Februar
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership26.2.2026 13:00:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the fourth quarter and full year 2025. “These strong financial results for the fourth quarter and full year 2025 underscore our continued evolution as a global oncology leader with durable competitive advantages in clinical development and manufacturing and one of the industry’s deepest and most differentiated pipelines,” said John V. Oyler, Co-Founder, Chairman and CEO at BeOne. “BRUKINSA has firmly established itself as the global leader in the BTK inhibitor class, distinguished by broad regulatory approvals, expanding geographic reach, strong physician adoption, and unmatched long-term efficacy and safety data in CLL. At the same time, we are securing new indications and expanded reimbursement for TEVIMBRA across key markets worldwide. With our late-stage, foundational hematology assets nearing commercialization and a robust solid tumo
Cyviz Unveils Containerized C2 Solution During HEIMDALL26.2.2026 12:00:00 EET | Press release
During Exercise HEIMDALL, organized by the Norwegian Joint Headquarters (FOH/NJHQ) this week, Cyviz is presenting its fully integrated, containerized solution for command, control, and collaboration environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226587573/en/ From deployment to operations: Cyviz’ container‑based C2 solution demonstrated during Exercise HEIMDALL. James Munt, Sales Director from Cyviz, took part in the demonstration. The solution is designed for secure, standardized, and agile operations, enabling operators to fight at the edge with assured information and supporting faster decision-making, in line with the company’s strategic focus on the defense and security sector. The container solution has been developed in collaboration with Nordic Shelter, providing the container platform. The modular platform combines control room technology, visualization, and software into one integrated system. It’s
ThreatAware Secures $25M from One Peak to Give Security Teams the Power to Build26.2.2026 12:00:00 EET | Press release
ThreatAware, the cyber asset management and cyber hygiene platform trusted by enterprises across sectors including retail, financial services, and energy, today announced it has raised $25 million in funding from One Peak, the growth equity firm specialising in high-growth software scale-ups. The investment will help ThreatAware scale its rapidly growing North American operations and accelerate its ambitious product roadmap, including the launch of ThreatAware's AI-powered security workspace. At the heart of ThreatAware's platform is its proprietary cyber asset management technology, which solves a problem most organisations don't even know they have. ThreatAware's data consistently reveals that, on average, 10% of devices accessing corporate networks go completely undetected by existing tools, while 30% of security controls are missing, misconfigured, or failing silently. As cloud adoption and remote working continue to expand the enterprise attack surface, these blind spots represent
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom